Boston Partners
DVAX

Boston Partners’s Dynavax Technologies DVAX Stock Holding History

Boston Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,507
Closed -$292K – 737
2024
Q1 		$292K Buy
+23,507
New +$307K ﹤0.01% 741
2016
Q3 		– Sell
-123,378
Closed -$1.8M – 737
2016
Q2 		$1.8M Buy
123,378
+498
+0.4% +$8.51K ﹤0.01% 656
2016
Q1 		$2.36M Buy
+122,880
New +$2.48M ﹤0.01% 591

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners's DVAX Position: Q2 2024 in Review

Boston Partners sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 23,507 shares — an estimated $292K sold.

Boston Partners first reported a position in DVAX in Q1 2016 and held it in 3 quarters. The position peaked at $2.36M in Q1 2016. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • Boston Partners reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • Boston Partners sold 23,507 Dynavax Technologies shares in Q2 2024, an estimated $292K.
  • Boston Partners first reported a position in Dynavax Technologies in Q1 2016 and held it in 3 quarters.
  • Boston Partners's Dynavax Technologies position peaked at $2.36M in Q1 2016.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.